598 filings
8-K
TXMD
TherapeuticsMD Inc
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
10-Q
2023 Q3
TXMD
TherapeuticsMD Inc
Quarterly report
14 Nov 23
12:00am
8-K
TXMD
TherapeuticsMD Inc
18 Aug 23
Entry into a Material Definitive Agreement
5:18pm
10-Q
2023 Q2
TXMD
TherapeuticsMD Inc
Quarterly report
14 Aug 23
7:30am
8-K
TXMD
TherapeuticsMD Inc
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
D
h8w6um3 nl9
10 Jul 23
Exempt offering of security
5:49pm
8-K
baxx58mnf9qlp
10 Jul 23
Changes in Registrant's Certifying Accountant
5:20pm
8-K
6p3j4x
6 Jul 23
Unregistered Sales of Equity Securities
4:38pm
8-K
ivkvv
28 Jun 23
Submission of Matters to a Vote of Security Holders
7:00am
ARS
ksgk9 2hzeq
17 May 23
Annual report to shareholders
5:52pm
DEFA14A
q0spcz88
17 May 23
Additional proxy soliciting materials
5:05pm
8-K
agac8me1xwtean0uhytb
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
51v3wuyx3jx9
5 May 23
Entry into a Material Definitive Agreement
5:26pm
8-K
y430ozf9
21 Apr 23
Other Events
5:14pm
8-K
j0c2oya07bdd 5e
7 Apr 23
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
4:41pm